Jane Street’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,949
| Closed | -$377K | – | 11002 |
|
|
2025
Q3 | $377K | Buy |
+7,949
| New | +$385K | ﹤0.01% | 8456 |
|
|
2025
Q2 | – | Sell |
-182,457
| Closed | -$8.29M | – | 9523 |
|
|
2025
Q1 | $7.39M | Sell |
182,457
-42,562
| -19% | -$1.8M | ﹤0.01% | 2378 |
|
|
2024
Q4 | $6.26M | Buy |
225,019
+7,455
| +3% | +$226K | ﹤0.01% | 2380 |
|
|
2024
Q3 | $6.24M | Sell |
217,564
-39,970
| -16% | -$1.04M | ﹤0.01% | 2506 |
|
|
2024
Q2 | $6.04M | Buy |
257,534
+7,459
| +3% | +$160K | ﹤0.01% | 2699 |
|
|
2024
Q1 | $6.32M | Sell |
250,075
-5,474
| -2% | -$131K | ﹤0.01% | 2312 |
|
|
2023
Q4 | $5.97M | Buy |
255,549
+79,513
| +45% | +$1.57M | ﹤0.01% | 2608 |
|
|
2023
Q3 | $8.9M | Sell |
176,036
-88,390
| -33% | -$4.12M | ﹤0.01% | 1902 |
|
|
2023
Q2 | $12.3M | Buy |
264,426
+203,790
| +336% | +$9.34M | ﹤0.01% | 1693 |
|
|
2023
Q1 | $2.32M | Buy |
60,636
+26,496
| +78% | +$1.18M | ﹤0.01% | 3562 |
|
|
2022
Q4 | $1.87M | Buy |
34,140
+26,236
| +332% | +$1.12M | ﹤0.01% | 3965 |
|
|
2022
Q3 | $269K | Sell |
7,904
-2,926
| -27% | -$44.8K | ﹤0.01% | 7751 |
|
|
2022
Q2 | $102K | Sell |
10,830
-15,822
| -59% | -$165K | ﹤0.01% | 8625 |
|
|
2022
Q1 | $378K | Sell |
26,652
-3,377
| -11% | -$59.1K | ﹤0.01% | 7984 |
|
|
2021
Q4 | $635K | Buy |
30,029
+5,996
| +25% | +$133K | ﹤0.01% | 6810 |
|
|
2021
Q3 | $538K | Buy |
24,033
+15,353
| +177% | +$348K | ﹤0.01% | 7146 |
|
|
2021
Q2 | $216K | Sell |
8,680
-2,304
| -21% | -$64.7K | ﹤0.01% | 8687 |
|
|
2021
Q1 | $319K | Buy |
+10,984
| New | +$332K | ﹤0.01% | 7603 |
|
Other funds holding AKRO
Jane Street's AKRO Position: Q4 2025 in Review
Jane Street sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 7,949 shares — an estimated $377K sold.
Jane Street first reported a position in AKRO in Q1 2021 and held it in 18 quarters. The position peaked at $12.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Jane Street reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Jane Street sold 7,949 Akero Therapeutics shares in Q4 2025, an estimated $377K.
- Jane Street first reported a position in Akero Therapeutics in Q1 2021 and held it in 18 quarters.
- Jane Street's Akero Therapeutics position peaked at $12.3M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.